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Abstract Phenomena related to chronic kidney disease,
such as atherosclerosis, aggravate with the introduction of
dialysis. Matrix metalloproteinases (MMP) and factors
modifying their activity, such as their tissue inhibitors (TIMP)
or neutrophil gelatinase-associated lipocalin (NGAL), take
part in the matrix turnover and the endothelial damage
characteristic for atherogenesis. However, there are no data
on the associations between these parameters and other
known pro-atherogenic factors, or on the impact of various
dialysis modalities on them. The aim of our study was to
assess the serum concentrations of NGAL, MMP-7, MMP-9,
and TIMP-1, as well as their correlations with human heat
shock proteins (Hsp90α, anti-Hsp60), endothelial dysfunc-
tion (sE-selectin), and inflammation (hsCRP) in pediatric
patients chronically dialyzed. Twenty-two children on auto-
mated peritoneal dialysis (APD), 17 patients on hemodialysis
(HD) and 24 controls were examined. The serum concen-
trations of NGAL, MMP-7, MMP-9, TIMP-1, Hsp90α,a n t i -
Hsp60, and sE-selectin were assessed by enzyme-linked
immunosorbentassay(ELISA).ThemedianvaluesofNGAL,
MMP-7, MMP-9, TIMP-1, and MMP-9/NGAL ratio were
significantly elevated in all dialyzed children vs. controls and
were higher in HD than in APD. The values of MMP-9/
TIMP-1 and MMP-7/TIMP-1 ratios in the HD subjects were
lower than those in the APD children. Hsp90α and anti-
Hsp60 predicted the values of NGAL, MMPs, and TIMP-1.
Additionally, sE-selectin was a predictor of NGAL levels,
whereas NGAL predicted the MMP and TIMP-1 concen-
trations. The increased concentrations of examined parame-
tersindicate the dysfunction of MMP/TIMP/NGAL system in
the dialyzed children, morepronounced on hemodialysis. The
discrepancies between dialysis modalities and correlations
with heat shock proteins (HSPs) suggest that NGAL may be
considered a novel stress protein, whereas MMP-7, MMP-9,
and TIMP-1 may be regarded as indicators of stress response
in the pediatric population on chronic dialysis.
Keywords Heat shock proteins.Hemodialysis.Peritoneal
dialysis.Matrix destruction.Lipids.Endothelial damage
Introduction
Inflammation, lipid disturbances, endothelial damage, and
autoimmunityplayapivotalroleinatherogenesis(Blasi2008;
Wick et al. 2004). The acceleration of atherosclerosis is
characteristic for the patients with chronic kidney disease,
and the aggravation of that process concerns particularly
those who are on dialysis (Andreoli et al. 2007).
Extracellular HSPs and their antibodies may also take
part in atherogenesis (Rigano et al. 2007; Leng et al. 2010).
The role for human HSPs in predicting the risk of acute
coronary syndrome and accelerating atherosclerosis has been
confirmed very recently (Dulin et al. 2010; Zhang et al.
2010). Moreover, generating anti-HSPs may be the result of
immune response against both human and bacterial HSPs
that have high-sequence homology (Pockley et al. 1999;W u
and Tanguay 2006). Such a cross-reactivity, excellently
exemplified by Hsp60 and anti-Hsp60 (Cappello et al.
2009), may disturb the immune response by triggering
reactions against own HSPs (Perschinka et al. 2003).
Another contribution of HSPs to innate immunity is their
ability to activate nuclear factor (NF)-κB—one of the potent
stimulators of MMP and TIMP secretion. Both human anti-
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Therefore, the HSP–anti-HSP system may have an
impact on the disturbed turnover of extracellular matrix,
which in turn is responsible for myocardial and vascular
remodeling. Indeed, mounting evidence points toward nox-
ious or protective effects of matrix metalloproteinases and
their tissue inhibitors on the development of atherosclerosis
(Johnson et al. 2005;K u z u y ae ta l .2006).
MMPs represent a family of endopeptidases with the
proteolytic activity, targeting the components of extracellular
matrix.Their activitycan beregulated byseveral factors,such
as NF-κB, cytokines or oxidative stress (Newby et al. 2009).
Such a variety of control pathways may be responsible for
their ambiguous effects. In detail, MMP-9 (gelatinase B) has
been described in in vitro investigations as a protector of the
plaque stability in its early stages and the promoter of the
increased vulnerability through hemorrhage in the advanced
lesions (Luttun et al. 2004; de Nooijer et al. 2006). MMP-9
is also one of the risk factors for myocardial infarction
(Jefferis et al. 2010). TIMP-1 is a specific inhibitor of MMP-
9, binding to it in a 1:1 proportion. The role of TIMP-1 in
atherogenesis is not clear, but its concentration correlates
positively with left ventricular mass and heart wall thickness
(Hansson et al. 2009).
Neutrophil gelatinase-associated lipocalin (NGAL; lip-
ocalin 2) is another specific MMP-9 binder, preventing it
fromdegradation and, thus, maintaining its activity. However,
lipocalin 2 occupies mainly an established position of a
markerofseverityofrenalimpairment(Bolignanoetal.2008;
Mitsnefes et al. 2007; Nishida et al. 2010). Recent studies
have also suggested its role in atherosclerosis and inflam-
mation. NGAL expression has been reported in atheroscle-
rotic plaques (Hemdahl et al. 2006), whereas the presence of
MMP-9/NGAL complex has been suggested indicative of
their erosion (Diamanti-Kandarakis et al. 2008). Moreover,
NGAL activity is regulated by IL-1β and NF-κB (Bu et al.
2006; Cowland et al. 2006). The in vitro experiments have
shown another side of the coin, because increased NGAL
concentrations could protect against thermal stress (Roudkenar
et al. 2009). However, the role of lipocalin 2 as a potential
stress marker in humans has not been tested yet.
The elevated serum concentrations of MMP-7 (matrily-
sin) were observed in patients with coronary artery disease
(Nilsson et al. 2006). However, nothing is known about the
role of MMP-7 in the subjects with chronic kidney disease,
or in the patients on dialysis.
The data on the role of circulating MMPs/TIMPs in end-
stage renal disease are scarce and concern mainly adult
patients on hemodialysis (Preston et al. 2002; Pawlak et al.
2005; Naganuma et al. 2008). Single studies have described
the role of MMP-9, TIMP-1, and NGAL as markers of
peritonitis in the patients on peritoneal dialysis (Fukudome
et al. 2001; Leung et al. 2009). There are no data so far on
these parameters in the pediatric patients on chronic dialysis
or studies comparing these parameters in the subjects
treated with different dialysis modalities.
Therefore, our aim was to assess the serum levels of
NGAL, MMP-7, MMP-9, and TIMP-1 in children on
peritoneal dialysis and hemodialysis, searching for the differ-
encesbetweenthesemodalities.Secondly,weinvestigatedthe
associations with human stress proteins (Hsp90α, anti-
Hsp60), endothelial markers (sE-selectin), and the known
markers of atherosclerosis, such as the lipid profile disturban-
ces or inflammation (hsCRP), to assess the role of MMP/
TIMP/NGAL system in stress response, in the acceleration of
atherosclerosis and in the differentiation between the various
dialysis modalities.
Materials and methods
Sixty-three patients enrolled in the study were divided into
three groups. Basic demographical data are put into the
Table 1.
The first group consisted of 22 children on automated
peritoneal dialysis (APD—Baxter, Home choice). The
patients had ten exchanges during the night and, if
necessary, one or two during the day. Peritoneal fluids
used in our patients had glucose concentrations varying
from 1.36% to 2.27%. The causative factors in CKD were:
chronic pyelonephritis (seven cases), chronic glomerulone-
phritis (six), polycystic kidney disease (two), neurogenic
bladder (three), hemolytic uremic syndrome (two), and
unknown (two).
The second group included 17 children and young adults
hemodialyzed (HD) on polysulfone membranes. HD ses-
sions (3.5–4 h) were performed three times a week, using
bicarbonate dialysate, the blood flow ranged from 150 to
200 ml/min, dialysate flow did not exceed 500 ml/min. The
membrane area was between 1.0 and 1.6 m
2, the dialyzers
were not reused. The water, purified by reosmosis, was
regularly checked for contamination. All patients were on
stable anticoagulation regimen using low molecular weight
heparin. The causative factors in chronic renal failure were:
chronic glomerulonephritis (six cases), chronic pyelone-
phritis (six), neurogenic bladder (two), polycystic kidney
disease (one), and unknown (two).
To avoid the possible impact of previous glomerulopathy
on the concentrations of examined parameters, the patients
on dialysis were subdivided into those with chronic
glomerulonephritis as an underlying cause of CKD (12
cases) and those with abnormalities within the urinary tract
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NGAL, HSP, MMP, or TIMP between these groups.
Twenty-four children with primary nocturnal enuresis
and normal kidney function, served as controls.
None of the patients showed clinical evidence of infection,
had diabetes, malignancies or vasculitides, smoked, took
antibiotics,corticosteroidsorimmunosuppressivetherapy.All
APD children had their blood pressure values below the 90th
percentile for smaller children and below 120/80 mmHg for
adolescents, according to the criteria of the fourth report on
high blood pressure in children and adolescents (National
2004), and did not require anti-hypertensives. The blood
pressure in our HD patients was within normal values
without medication (12 patients) or was well controlled with
the use of ACE inhibitors only (three) or ACE inhibitors
with calcium channel blockers (two).
Informed consent was obtained from the subjects and
their parents, if necessary. The research project has been
approved by the University ethics committee, in accordance
with the Helsinki declaration.
Blood samples were drawn after an overnight fast from
peripheral veins in APD patients and controls, in HD
subjects—from the afferent line of the first-use dialyzer
before starting an HD session. Samples were clotted for
30 min, centrifuged at 4°C for 10 min, and then serum was
stored at −20°C until assayed. Serum concentrations of
NGAL, MMP-7 (matrilysin), MMP-9 (gelatinase B), and
TIMP-1 were evaluated by commercially available ELISA
kits (R&D Systems, Abingdon, UK). Standards and serum
samples were transferred to 96 well microplates pre-coated
with recombinant antibodies to human NGAL, MMP-7,
MMP-9 and TIMP-1. Each sample was tested in duplicate
and the arithmetical mean was considered a final result.
Measurements were performed according to the manufac-
turer’s instructions; results were calculated by reference to
standard curves.
The methods of evaluation of human Hsp90α, anti-
Hsp60 and sE-selectin were described in our previous
publication (Musiał et al. 2009).
In all patients the lipid profile (total cholesterol, HDL-
cholesterol, LDL-cholesterol, triglycerides, by BioSystems,
Barcelona, Spain) and hsCRP as a marker of inflammation
(nephelometry by Dade Behring, Marburg, Germany) were
also evaluated.
Statistical analysis
Resultsareexpressedasmedianvaluesandinterquartileranges.
Differences between all groups were evaluated by using
nonparametric tests (Kruskal–Wallis, Mann–Whitney U). The
relations between parameters were assessed by linear regres-
sion analysis. The linear regression equations were calculated
as y ¼ bx þ a (y—dependent variable, β—regression coeffi-
cient, x—independent variable, a—constant term). We pre-
sented only those equations where both regression coefficient
and constant term were statistically significant. Statistical
analysis was performed using the package Statistica ver. 8.0.
A p value <0.05 was considered significant.
Results
Neutrophil gelatinase-associated lipocalin, MMPs, TIMP
NGAL, MMP-7, MMP-9, and TIMP-1 concentrations were
significantly increased in all dialyzed children when
compared to controls (p<0.01) and the levels in the HD
subgroup were higher than in the APD subjects (Fig. 1a–d).
In regard to TIMP-1, this increase was most evident (2.6-
fold), contrarily to the 1.2-fold elevation of NGAL, MMP-7
and MMP-9 in the HD subjects when compared to the APD
children.
Parameter Median values (interquartile ranges) of analyzed parameters
Control gr. (n=24) APD (n=22) HD (n=17)
Age (years) 10.5 (5.0–16.5) 10.0 (4.0–15.5) 14.0 (10.5–17.5)
Gender 13 girls; 11 boys 12 girls; 10 boys 9 girls; 8 boys
Time of therapy (years) – 2.0 (0.7–2.5) 2.1 (1.4–2.5)
Hsp90α (ng/ml) 5.0 (4.5–5.5)
a 28.5 (20.0–36.0) 25.0 (20.0–25.0)
c
Anti-Hsp60 (ng/ml) 11.3 (8.2–26.7)
a 49.3 (14.85–71.85)
b 99.2 (90.7–121.78)
c
sE-selectin (ng/ml) 26.1 (22.2–28.0)
a 92.0 (82.0–96.0)
b 104.0 (94.0–108.0)
c
hsCRP (mg/l) 0.33 (0.21–0.63) 0.52 (0.22–2.80) 0.24 (0.16–0.57)
Total CHOL (mg/dl) 188.0 (181.0–196.0)
a 221.0 (212.0–275.0) 220.0 (180.0–250.0)
HDL-CHOL (mg/dl) 62.0 (59.0–67.0)
a 43.25 (40.0–48.0) 44.0 (41.0–45.0)
c
LDL-CHOL (mg/dl) 99.5 (91.0–109.0)
a 128.5 (111.0–169.0) 134.0 (120.0–180.0)
c
triglycerides (mg/dl) 86.0 (66.5–100.0)
a 144.5 (116.0–199.5)
b 110 (90.0–120.0)
c
Table 1 The median values and
interquartile ranges of basic
demographical data and exam-
ined parameters in the patients
on peritoneal dialysis (APD),
on hemodialysis (HD) and
in the control group
Mann–Whitney U test:
ap<0.01 APD vs. control group
bp<0.05 APD vs. HD
cp<0.01 HD vs. control group
NGAL in children on chronic dialysis 165Matrix metalloproteinase-7/TIMP-1, MMP-9/TIMP-1,
and MMP-9/NGAL ratios
The values of MMP-7/TIMP-1 ratio were decreased in the
patients on dialysis, being the lowest in the hemodialyzed
subjects (Table 2). The MMP-9/TIMP-1 ratio was increased
both in the APD and in the HD patients vs. controls, and the
values in children on peritoneal dialysis were 2.2 times higher
than those in the HD subjects (Table 2). The MMP-9/NGAL
ratio was the only one that remained increased in children on
dialysis in comparison to the control group and was higher in
the HD patients than in the APD children (Table 2).
 median 
 25%-75% 
 min - max 
Control gr APD HD
Examined groups
30
40
50
60
70
80
90
100
S
e
r
u
m
 
N
G
A
L
 
[
m
g
/
m
l
] x 1.3
x 2.1
APD vs. HD
p < 0.01
APD vs. control gr. 
HD vs. control gr.
p < 0.01
Control gr APD HD
Examined groups
1,5
2,0
2,5
3,0
3,5
4,0
4,5
5,0
5,5
S
e
r
u
m
 
M
M
P
-
7
 
[
n
g
/
m
l
]
APD vs. control gr.
HD vs. control gr.
p < 0.01
x 1.2
x 1.9
APD vs. HD
p < 0.01
Control gr APD HD
Examined groups
0
100
200
300
400
500
600
700
800
900
1000
S
e
r
u
m
 
M
M
P
-
9
 
[
n
g
/
m
l
]
x 1.2
x 6.5
APD vs. control gr.
HD vs. control gr.
p < 0.01
APD vs. HD
p < 0.01
 median 
 25%-75% 
 min - max 
Control gr APD HD
Examined groups
0
100
200
300
400
500
600
S
e
r
u
m
 
T
I
M
P
-
1
 
[
n
g
/
m
l
]
APD vs. control gr.
HD vs. control gr.
p < 0.01
x 2.6
x 2
APD vs. HD
p < 0.01
a
c
b
d
 median 
 25%-75% 
 min - max 
 median 
 25%-75% 
 min - max 
Fig. 1 The serum concentrations of examined parameters (a NGAL; b MMP-7; c MMP-9; d TIMP-1) in children on peritoneal dialysis (APD)o n
hemodialysis (HD) and in the control group
Table 2 The median values and interquartile ranges of the ratios of examined parameters in children on peritoneal dialysis (APD), on
hemodialysis (HD) and in the control group
Parameter median values (interquartile ranges) Control group N=24 APD N=22 HD N=17
MMP-9/TIMP-1 ratio 1.43
a (1.19–1.65) 4.0
b (3.81–4.58) 1.76
c (1.68–1.81)
MMP-7/TIMP-1 ratio 0.030
a (0.026–0.037) 0.026
b (0.025–0.030) 0.011
c (0.010–0.012)
MMP-9/NGAL ratio 2.71
a (2.61–2.96) 8.08
b (7.66–8.36) 8.46
c (8.23–8.94)
Mann–Whiney U test:
ap<0.01 APD vs. controls
bp<0.01 APD vs. HD
cp<0.01 HD vs. controls
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Hsp90α, anti-Hsp60, and sE-selectin serum concentrations
in the dialyzed population were significantly higher than in
the control group (Table 1). Anti-Hsp60 and sE-selectin
levels were also increased in the patients on hemodialysis
when compared with those on peritoneal dialysis.
hsCRP, the lipid profile
High sensitivity CRP levels did not show significant differ-
ences between dialyzed children and controls (Table 1). Total
cholesterol was significantly elevated only in the APD
children (Table 1). HDL-cholesterol concentrations were
decreased, whereas those of LDL-cholesterol and triglycer-
ides were increased in patients on dialysis versus controls.
However, only in the case of triglycerides there was a
significant difference between the HD and APD subjects, the
latter being significantly higher (Table 1)
Linear regression analysis
In all dialyzed patients, NGAL, MMPs, and TIMP-1
correlated with each other. We have also found correlations
between the above mentioned parameters and other
examined markers.
In detail, Hsp90α, anti-Hsp60 and triglycerides predicted
the values of MMP-7, MMP-9, TIMP-1, MMP-7/TIMP-1,
and MMP-9/TIMP-1 ratios (Tables 3 and 4).
sE-selectin, Hsp90α, and anti-Hsp60 were the predictors
of NGAL, whereas NGAL itself predicted MMP-7, MMP-
9, and TIMP-1 values (Table 3), as well as MMP-7/TIMP-1
and MMP-9/TIMP-1 ratios (Table 4).
In regard to MMP-9/NGAL ratio, such a prediction
concerned only anti-Hsp60 (Table 4).
No associations between MMP/TIMP/NGAL and
hsCRP were observed.
Discussion
Our study describes for the first time the disturbed NGAL
and MMP/TIMP systems in children with end-stage renal
failure on dialysis.
The NGAL concentrations in the dialyzed patients were
elevated when compared to controls and higher in the
subjects on HD than in children on APD. Although the
increased levels of NGAL in adults on chronic hemodial-
ysis, as well as their correlation with inflammation markers,
have been confirmed recently (Małyszko et al. 2009), there
are no studies assessing lipocalin 2 in the light of different
dialysis modalities. Therefore, the interpretation of elevated
serum NGAL concentrations seems difficult.
Indeed, increased lipocalin 2, apart from being a marker
of renal insufficiency, can also be the response to oxidative
or thermal stresses (Roudkenar et al. 2007; Roudkenar et al.
2009). It was shown that NGAL expression increased in a
mouse kidney exposed to cold or heat stress (Roudkenar et al.
2009). Moreover, the in vitro investigation on human
embryonic kidney cells (HEK293T) revealed the protective
and anti-apoptotic role of NGAL against thermal stress. In
detail, the addition of recombinant NGAL to HEK293T,
prior to cold stress or after heat exposure, protected those
cells against the stress-induced apoptosis (Roudkenar et al.
2009). Thus, it was proven that NGAL behaved like a
classical stress protein. From this point of view, the difference
Dependent
variable
Independent
variable
Regression
coefficient β
Constant
term
95% confidence
interval (CI)
p
MMP-7 (ng/ml) Hsp90α (ng/ml) 0.007 3.99 4.19–4.29 0.00
Anti-Hsp60 (ng/ml) 0.004 4.09 4.35–4.52 0.00
Triglycerides (mg/dl) −0.002 4.71 4.36–4.55 0.02
NGAL (ng/ml) 0.03 1.74 4.25–4.39 0.00
MMP-9 (ng/ml) Hsp90α (ng/ml) 1.49 595.19 624.79–670.16 0.00
Anti-Hsp60 (ng/ml) 1.17 602.04 667.49–717.35 0.00
Triglycerides (mg/dl) −0.55 763.04 671.33–722.71 0.03
NGAL (ng/ml) 6.72 135.70 642.85–690.85 0.00
TIMP-1 (ng/ml) Hsp90α (ng/ml) 3.38 61.14 160.68–198.04 0.00
Anti-Hsp60 (ng/ml) 2.30 99.28 240.45–315.32 0.00
Triglycerides (mg/dl) −1.19 440.15 250.72–342.19 0.01
NGAL (ng/ml) 15.54 −999.39 189.88–266.26 0.00
NGAL (ng/ml) Hsp90α (ng/ml) 0.13 74.63 78.33–79.80 0.00
Anti-Hsp60 (ng/ml) 0.06 77.25 79.29–83.84 0.03
sE-selectin (pg/ml) 0.21 61.47 79.55–82.98 0.01
Table 3 The statistically
significant correlations
between the examined
parameters assessed by linear
regression analysis in all
children and young adults
on dialysis (APD+HD)
NGAL in children on chronic dialysis 167between patients on peritoneal dialysis and hemodialysis
would confirm that the latter is more stress-inducing.
The discrepancy in NGAL elevation between two
different modalities could also result from the neutrophil
sequestration, taking place during every hemodialysis
session (Andreoli et al. 2007). Another interesting finding
was the existence of correlations between NGAL and heat
shock proteins. The possible explanation for such connec-
tion might be the impact of NF-κB, which is upregulated by
HSPs and then may trigger NGAL activity (Bu et al. 2006;
Cowland et al. 2006). Additionally, the prediction of
lipocalin 2 values by sE-selectin may point to relations
between NGAL and endothelial damage. The intriguing
ability of NGAL, similar to that of Hsp90α and anti-Hsp60,
to predict MMP-7, MMP-9, and TIMP-1 concentrations in
the whole population on dialysis, suggests that lipocalin 2
may share some common features with HSPs. Whether this
could be another proof of its activity as a stress marker,
seems so far an open question that needs further in-depth
investigation before it can be definitely answered.
On the other hand, NGAL, by the blockage of MMP-9,
prevents it from degradation. Therefore, the MMP-9
elevation, observed in our patients, may, at least partially,
depend on the NGAL increase. Whatever the underlying
cause is, elevated serum MMP-9 concentrations, observed
in all dialyzed children, suggest the proteolytic overactivity
in that group of patients. The potential dialysis-related
trigger factors responsible for such conditions are multiple,
since close relations of MMP/TIMP system with oxidative
stress and inflammation in patients on hemodialysis have
been described recently (Pawlak et al. 2005). The correla-
tion with fibrotic processes has also been suggested (Rysz
et al. 2010), although the authors observed decreased
MMP-9 levels in adults on hemodialysis. The cause for
such discrepancies may lie in the number of examined
patients, not exceeding 20 subjects in all cited papers.
However, in the case of children such situation is
conditioned by the small size of overall pediatric population
on dialysis. Another interesting finding was the difference
in MMP-9 concentrations between HD and APD subjects.
There is only one study (Ebihara et al. 1998) that describes
the increased levels of MMP-9 mRNA in peripheral blood
monocytes of dialyzed patients, being higher in HD patients
than in CAPD subjects and, thus, confirming our results.
The differences between dialysis modalities may also be
explained, at least in part, by the results of the in vitro and
animal studies. Misra et al. have described the upregulation
of MMP-9, induced by the wall shear stress, in the
hemodialysis grafts of rats (Misra et al. 2008). Reno et al.
have shown the increased granulocyte adhesion and MMP-
9 release due to the contact with artificial surface, thus
suggesting the possible impact of the dialyzer in the HD
patients on the elevated gelatinase B concentrations, when
compared with the APD subjects (Reno et al. 2004). Last,
but not least, the already mentioned impact of NGAL may
be of importance. The influence of lipocalin 2 may partially
explain both the difference between dialysis modalities and
the fact that the MMP-9 concentrations in children on APD
exceeded those in controls nearly 7-fold, whereas in the
case of MMP-7, TIMP-1 or NGAL this rise was only 2-
fold. We have also observed that Hsp90α and anti-Hsp60
could predict the values of MMP-9, indicating its potential
role as a stress marker in the dialyzed pediatric population.
This finding is a novelty, not reported so far except for our
similar observations concerning children with chronic
kidney disease in a pre-dialysis state (Musiał et al. CSAC
2010). The reason for such a connection may be the
functional chain, starting with HSPs that trigger nuclear factor
(NF)-κB activity, which in turn upregulates MMPs and TIMP-
1 (Schett et al. 1995; Madrigal-Matute et al. 2010). The same
correlation in the case of triglycerides slightly suggests the
possible connection of MMP-9 with atherogenesis.
T h ed a t ao nM M P - 7a r eb a s e dm a i n l yo na n i m a l
investigation, showing its pro-atherogenic activity in the
tissue remodeling in heart failure and the reduction of smooth
muscle content in atherosclerotic plaque (Boixel et al. 2003;
Johnson et al. 2005). The study in patients with coronary
artery disease (CAD) has revealed the increased MMP-7
Dependent
variable
Independent
variable
Regression
coefficient β
Constant
term
95% confidence
interval (CI)
p
MMP-7/TIMP-1 ratio Hsp90α (ng/ml) −0.0002 0.03 0.024–0.028 0.00
Anti-Hsp60 (ng/ml) −0.0001 0.03 0.018–0.023 0.00
Triglycerides (mg/dl) 0.0001 0.01 0.016–0.022 0.02
NGAL (ng/ml) −0.0009 0.09 0.021–0.027 0.00
MMP-9/TIMP-1 ratio Hsp90α (ng/ml) −0.03 5.06 3.67–4.33 0.00
Anti-Hsp60 (ng/ml) −0.02 4.74 2.74–3.51 0.00
Triglycerides (mg/dl) 0.01 1.82 2.54–3.41 0.02
NGAL (ng/ml) −0.13 14.14 3.17–3.92 0.00
MMP-9/NGAL ratio Anti-Hsp60 (ng/ml) 0.009 7.79 8.15–8.88 0.03
Table 4 The statistically signif-
icant correlations between the
ratios of examined parameters
assessed by linear regression
analysis in all children and
young adults on dialysis
(APD+HD)
168 K. Musiał, D. Zwolińskaconcentrations, unrelated to the inflammation markers, in
both stable and unstable CAD (Nilsson et al. 2006). Nothing
is known about matrilysin in patients with chronic kidney
disease. Our study has shown its increased concentrations in
children and young adults on dialysis, the values in the HD
subjects being higher than those in the APD children,
similarly to MMP-9. Therefore, together with the observed
correlations between MMP-7, heat shock proteins and
triglycerides, we can cautiously speculate once again on
t h ep o s s i b l er o l eo fm a t r i l y s i na san e wm a r k e ro fs t r e s s
response and atherogenesis.
TIMP-1 concentrations rose in both APD and HD
subjects, although the difference in favor of HD (2.6-fold
higher than APD) was more evident than in the case of
other examined molecules (MMP-7 and MMP-9 levels
were 1.2–1.3-fold higher in HD than in APD). Our previous
results concerning CKD children treated conservatively have
shown that TIMP-1 elevation appears in the late stages of
CKD, being preceded by the MMP-9 increase (Musiał et al.
CSAC2010). Therefore, we can suspect that growing TIMP-
1 concentrations compensate the changes in MMP-9 levels.
Possibly, the increase triggered during the hemodialysis
session, caused by additional release of TIMP-1 from
platelets, could be the explanation for the fact that the
difference between APD and HD is more evident than in the
case of MMPs or NGAL (Villeneuve et al. 2009). Similarly
to MMPs, prediction of TIMP-1 by HSPs and triglycerides
implies the possibility of its application as stress and
atherogenesis- related marker.
Taken together, the fact that NGAL, MMP-9, and MMP-
7 values were all 1.2-fold higher in patients on hemodial-
ysis than in the subjects dialyzed peritoneally, may suggest
the common pathway of such elevation, possibly reliant on
the blood-dialyzer contact.
Finally, we decided to analyze the net effect of MMP/TIMP/
NGAL activity by evaluating the balance between MMPs, their
inhibitor and NGAL. Therefore, we assessed the values of
ratios between selected parameters. The median values of
MMP-7/TIMP-1 and MMP-9/TIMP-1 ratios were higher in
APD than in HD patients. In both cases TIMP-1 elevation in
HD patients was more pronounced than that of MMP-7 and
MMP-9, resulting in the decrease of ratio value vs. APD
children.This might be due to thepreviouslymentioned release
of TIMP-1 from platelets during hemodialysis. It may also
mean that high activity of metalloproteinases, pronounced on
hemodialysis, requires more intense suppression. The median
values of MMP-9/NGAL ratio were higher in the dialyzed
population than in controls, due to MMP-9 elevation (6.5-fold)
dominant over NGAL increase (2.1-fold). As expected,
Hsp90α, anti-Hsp60, and triglycerides were predictors of
MMP-7/TIMP-1 and MMP-9/TIMP-1 ratio values.
On the whole, the values of all examined parameters
were elevated in patients on dialysis compared to controls.
Moreover, the comparison of MMP/TIMP values between
previously evaluated CKD children (Musiał et al. CSAC
2010) and presently examined population revealed that the
concentrations in dialyzed subjects were significantly
higher. This observation confirms the impact of dialysis
per se on the examined parameters. Besides, the values of
assessed markers remained higher on hemodialysis than in
childrenonperitonealdialysis.Therefore,wemayhypothesize
that although proteolytic overactivity is seen in every subject
on dialysis, it prevails in HD. Since peritoneal dialysis is the
first choice therapy in CKD children, our results are of clinical
importance, speaking in favor of PD as a method triggering
proteolytic activity and stress reactions to a lesser extent.
Additionally, the correlations we observed between
examined parameters, heat shock proteins and triglycerides,
suggest the probable role for components of NGAL/MMP/
TIMP system as possible markers of stress response and
atherosclerosis development.
Finally, we are aware of the limitations of our study. Due
to the fact that there are no comparative data on relations
between NGAL, MMPs, TIMPs, and HSPs, our hypotheses
and conclusions had to be cautious. The multiplicity of
correlations between examined parameters strongly sug-
gests the existence of a functional network, probably
engaging other factors that we have not assessed. More-
over, the size of evaluated groups, conditioned by the
overall small population of children on dialysis, restricts the
power of conclusions that can be drawn. Therefore, the
meaning of the interplay between matrix metalloproteinases
and heat shock proteins, as well as the role of NGAL as a
novel stress marker, needs further investigation.
Conclusions
The increased concentrations of examined parameters suggest
the disturbances in NGAL/MMP/TIMP system in pediatric
population with end-stage renal disease on chronic dialysis.
Those abnormalities are more pronounced in patients on
hemodialysis than in those dialyzed peritoneally. Our investi-
gation has revealed that NGAL, correlating with heat shock
proteins and sharing common features with them, may serve as
a novel stress marker in children and young adults chronically
dialyzed. Correlations between MMP/TIMP, HSPs, and trigly-
cerides suggest that MMP-7,MMP-9, and TIMP-1may alsobe
regarded as indicators of stress response and atherosclerosis
development in pediatric population on chronic dialysis.
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